News Detail
Cambridge, 19 Sept 2023: COVID-19 patients are often prescribed antiviral drugs that work by reducing the number of viral particles circulating in the body. One such drug, View Details
Source : Harvard Gazette
Anne Manning
coronavirus
COVID-19
Department of Organismic and Evolutionary Biology
evolutionary safety
FAS
Martin Nowak
Mathematics
molnupiravir
virus mutations
Related News
- Study Identifies Hundreds of Potential Targets for Cancer Drugs (12-09-2024)
- Protein-lipid particles to deliver genetic medicine (11-09-2024)
- Harnessing bacteriophages as targeted treatments for drug-resistant bacteria (06-09-2024)
- Chinese scientists claim to have developed hydrogel to treat arthritis: Report (03-09-2024)
- Human gut microbiome: A source of new antibiotic peptides (26-08-2024)
- IIT Kanpur-KGMU together developed a special device, to give easily CPR at home (01-08-2024)
- Scientists control bacterial mutations to preserve antibiotic effectiveness (27-07-2024)
- Dual action antibiotic could make bacterial resistance nearly impossible (25-07-2024)
- Metoprolol, Tamsulosin and Bromocriptine combination treatment shows promise in the treatment of retinal degenerations (23-07-2024)
- Rotifer acquire genes from bacteria that can produce antibiotics (21-07-2024)